The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanley, S. A.
Right arrow Articles by Cox, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanley, S. A.
Right arrow Articles by Cox, J. S.
The Journal of Immunology, 2007, 178: 3143-3152.
Copyright © 2007 by The American Association of Immunologists, Inc.

The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1

Sarah A. Stanley, James E. Johndrow, Paolo Manzanillo and Jeffery S. Cox2

Department of Microbiology and Immunology, University of California, San Francisco, CA 94158

The ESX-1 secretion system is a major determinant of Mycobacterium tuberculosis virulence, although the pathogenic mechanisms resulting from ESX-1-mediated transport remain unclear. By global transcriptional profiling of tissues from mice infected with either wild-type or ESX-1 mutant bacilli, we found that host genes controlled by ESX-1 in vivo are predominantly IFN regulated. ESX-1-mediated secretion is required for the production of host type I IFNs during infection in vivo and in macrophages in vitro. The macrophage signaling pathway leading to the production of type I IFN required the host kinase TANK-binding kinase 1 and occurs independently of TLR signaling. Importantly, the induction of type I IFNs during M. tuberculosis infection is a pathogenic mechanism as mice lacking the type I IFNR were more restrictive for bacterial growth in the spleen than wild-type mice, although growth in the lung was unaffected. We propose that the ESX-1 secretion system secretes effectors into the cytosol of infected macrophages, thereby triggering the type I IFN response for the manipulation of host immunity.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants AI63302 and AI51667 (to J.S.C.). J.S.C. gratefully acknowledges the support of the Sandler Family Supporting Foundation and the W. M. Keck Foundation.

2 Address correspondence and reprint requests to Dr. Jeffery S. Cox, Department of Microbiology and Immunology; University of California, San Francisco, MBGH N372B, San Francisco, CA 94158. E-mail address: jeffery.cox{at}ucsf.edu

3 Abbreviations used in this paper: IFNAR1, IFNR{alpha}1; BMDM, bone marrow-derived macrophage; CFP-10, culture filtrate protein-10; ESAT-6, early secreted antigenic target-6; IP-10, IFN-{gamma}-inducible protein-10; IRF, IFN regulatory factor; MEEBO, Mouse Exonic Evidence-Based Oligonucleotide; MOI, multiplicity of infection; Nod, nucleotide-binding oligomerization domain protein; RIP2, receptor-interacting protein 2; SAM, Statistical Analysis of Microarray; TBK1, TANK-binding kinase 1; WT, wild type.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
G. T. Crimmins, M. W. Schelle, A. A. Herskovits, P. P. Ni, B. C. Kline, N. Meyer-Morse, A. T. Iavarone, and D. A. Portnoy
Listeria monocytogenes 6-Phosphogluconolactonase Mutants Induce Increased Activation of a Host Cytosolic Surveillance Pathway
Infect. Immun., July 1, 2009; 77(7): 3014 - 3022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. V. Pichugin, B.-S. Yan, A. Sloutsky, L. Kobzik, and I. Kramnik
Dominant Role of the sst1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts
Am. J. Pathol., June 1, 2009; 174(6): 2190 - 2201.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Giacomini, M. E. Remoli, V. Gafa, M. Pardini, L. Fattorini, and E. M. Coccia
IFN-{beta} improves BCG immunogenicity by acting on DC maturation
J. Leukoc. Biol., March 1, 2009; 85(3): 462 - 468.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. T. Crimmins, A. A. Herskovits, K. Rehder, K. E. Sivick, P. Lauer, T. W. Dubensky Jr., and D. A. Portnoy
Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity
PNAS, July 22, 2008; 105(29): 10191 - 10196.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
C. A. Huber, M.-T. Ruf, G. Pluschke, and M. Kaser
Independent Loss of Immunogenic Proteins in Mycobacterium ulcerans Suggests Immune Evasion
Clin. Vaccine Immunol., April 1, 2008; 15(4): 598 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yang, C. Yin, A. Pandey, D. Abbott, C. Sassetti, and M. A. Kelliher
NOD2 Pathway Activation by MDP or Mycobacterium tuberculosis Infection Involves the Stable Polyubiquitination of Rip2
J. Biol. Chem., December 14, 2007; 282(50): 36223 - 36229.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. I. de Jonge, G. Pehau-Arnaudet, M. M. Fretz, F. Romain, D. Bottai, P. Brodin, N. Honore, G. Marchal, W. Jiskoot, P. England, et al.
ESAT-6 from Mycobacterium tuberculosis Dissociates from Its Putative Chaperone CFP-10 under Acidic Conditions and Exhibits Membrane-Lysing Activity
J. Bacteriol., August 15, 2007; 189(16): 6028 - 6034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.